Decode Biology with Computational Precision.
Nutracie bridges generative AI and molecular biology to accelerate drug discovery, genomic analysis, and protein engineering: from hypothesis to clinical candidate in months, not years.
2.1B+
Molecular structures analyzed
340+
Research publications
89%
Target prediction accuracy
47
Pharma partnerships
Platform Performance
Benchmarked Against the Best
Real-world performance metrics across drug discovery, genomics, and protein structure prediction.
Accuracy Metrics
Target Prediction
Protein Folding
Variant Calling
Drug-Target Binding
Processing Throughput
Nutracie vs Traditional Methods
Drug candidate discovery
Protein structure prediction
Genomic variant analysis
Multi-omics integration
The Nutracie Platform
End-to-End AI for Life Sciences
Four integrated products powering every stage of biological research, from target discovery to protein engineering.
NutraDiscover™
AI-powered drug target identification and molecular design engine. Leverages transformer architectures trained on 2.1B+ compound-target interactions.
Learn moreNutraGenome™
End-to-end genomic analysis platform with variant calling, pathway enrichment, and polygenic risk scoring powered by proprietary deep learning models.
Learn moreNutraOmics™
Integrated multi-omics analysis suite unifying transcriptomics, proteomics, and metabolomics data into actionable biological insights.
Learn moreNutraFold™
State-of-the-art protein structure prediction using equivariant graph neural networks, enabling rapid structure-based drug design.
Learn moreActive Pipeline
Drug Discovery Pipeline
Real-time view of active programs across all stages of the discovery funnel. AI-driven candidate generation has increased our clinical-stage conversion rate by 3.2x.
48
Active programs
3.2x
Higher conversion rate
67%
Faster hit-to-lead
$2.4M
Avg. savings per program
Discovery Funnel: Active Programs
Live Demo
A Glimpse Inside Nutracie
Real-time inference, federated nodes, and discovery pipelines, orchestrated from one workspace.
Sequences / sec
18,240
+6.1%Model confidence
96.3%
+0.8%Active pipelines
52
liveGPU utilization
78%
stableSystem log
› PROTEIN_FOLD_RECONSTRUCTION → success (0.31s)
› DRUG_TARGET_SCAN BRCA1:chr17:43044295 → confidence 0.982
› FEDERATED_NODE us-west-2-a sync OK
› VARIANT_ANNOTATION batch_12847 → 3,241 variants classified
› MOLECULAR_GEN candidate_set_42 → 18 novel compounds generated
› MULTI_OMICS_INTEGRATION cohort_n=2,840 → pathway enrichment complete
Enterprise-Grade Infrastructure
Built for the rigorous demands of pharmaceutical R&D and academic research.
GPU-Accelerated
NVIDIA A100/H100 optimized inference pipelines
HIPAA Compliant
SOC 2 Type II certified, end-to-end encryption
Real-time Analysis
Sub-second inference on genomic queries
Federated Compute
Distributed processing across global nodes
Interactive Viz
Publication-ready plots and molecular viewers
API-First
RESTful & GraphQL APIs with Python/R SDKs
Trusted by Industry Leaders · Built on World-Class Infrastructure
Ready to Accelerate Your Research?
Join 47 pharmaceutical partners and 200+ research institutions using Nutracie to redefine the future of drug discovery.